Skip to content

A study to evaluate the impact of test food ingestion on cerebral blood flow

A study to evaluate the impact of test food ingestion on cerebral blood flow - A study to evaluate the impact of test food ingestion on cerebral blood flow

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035521
Enrollment
50
Registered
2020-09-30
Start date
2019-02-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy people

Interventions

Intake of the test food (6 weeks). Intake of control food (6 weeks).

Sponsors

KT Medical Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Adult of both sexes aged from 45 to 60 years old at time of informed consent provided 2)Subjects confirmed to be healthy on pre-observation inspection 3)Subjects who are right handed 4)Subjects whose native language is Japanese 5)Subjects who are competent to consent and give voluntary consent in writing with full understanding after receiving explanation of this study aim and contents

Exclusion criteria

Exclusion criteria: 1.Subjects with current medical history and history of serious disorders that influence this study 2.Subjects with surgical history of head or foreign metal in their head 3.Subjects who are under hormone treatment, or who have been diagnosed as climacterium 4.Subjects with history of heart disease or heart pacemakers 5.Subjects with pollen allergy 6.Subjects with difficulty of color discrimination 7.Subjects whose visual or hearing acuity is too low to perform tests, or who have been diagnosed as amblyopia, blindness, or deafness 8.Subjects who may have physical deconditioning due to test foods 9.Subjects who have diseases requiring regular administration, or who have anamnesis of severe diseases 10.Subjects who are under treatment for brain function, or who regularly intake drugs or health foods that influence brain function more than once a week 11.Subjects who regularly intake drugs or health foods that influence cerebral blood flow more than once a week 12.Subjects who regularly intake foods resembling test food or energy drink more than once a week 13.Subjects who are, or are planning to be pregnant or nursing during study 14.Subjects who sometimes have irregular lifestyles during study 15.Subjects who regularly drink alcohol beyond proper quantity 16.Smokers, or subjects who initiated smoking cessation within 12 months 17.Subjects who undergo brain function tests within 12 months 18.Subjects who make 200 mL or 400 mL blood donation within 3 months 19.Subjects who are participating in other clinical trials within 1 month or who are planning to participate in other clinical trials during study 20.Subjects who are suspected of dementia 21.Subjects considered to be unsuitable for enrollment based on lifestyle questionnaire or cerebral blood flow measurement 22.Subjects who work in a company developing functional foods 23.Subjects who are judged as unsuitable by doctor

Design outcomes

Primary

MeasureTime frame
Cerebral blood flow

Secondary

MeasureTime frame
Correlation between each result including cerebral blood flow

Countries

Japan

Contacts

Public ContactShigeru Imai

KT Medical Corporation Food clinical trial Division

imai@kt-medical.co.jp03-5223-8811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026